Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24 separator commenting unavailable

COVID-19 vaccination recommendations prioritise healthcare workers (HCWs), considering their exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) and their key role in the functioning of healthcare systems. In the European Union/European Economic Area (EU/EEA), HCWs were considered a prio...

Full description

Bibliographic Details
Authors: Savulescu, Camelia, Prats Uribe, Albert, Brolin, Kim, Uusküla, Anneli, Bergin, Colm, Fleming, Catherine, Murri, Rita, Zvirbulis, Viesturs, Zavadska, Dace, Gaio, Vania, Popescu, Corneliu P., Hrisca, Raluca, Cisneros, Maria, Latorre-Millán, Miriam, Lohur, Liis, McGrath, Jonathan, Ferguson, Lauren, De Gaetano Donati, Katleen, Abolina, Ilze, Gravele, Dagne, Machado, Ausenda, Florescu, Simin-Aysel, Lazar, Mihaela, Subirats, Pilar, Clusa, Laura, Sui, Jacklyn, Kenny, Claire, Santangelo, Rosaria, Krievins, Dainis, Barzdina, Elza Anna, Valadas Henriques, Camila, Kosa, Alma Gabriela, Pohrib, Saftica-Mariana, Muñoz-Almagro, Carmen, Milagro Beamonte , Ana, Bacci, Sabrina, Nardone, Anthony, VEBIS HCW VE study group
Format: article
Publication Date:2024
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:20.500.12328/4484
Online Access:http://hdl.handle.net/20.500.12328/4484
https://dx.doi.org/10.2807/1560-7917.ES.2024.29.44.2400680
Access Level:Open access
Keyword:COVID-19
Vacunació
Vacunación
Vaccination
61
Description
Summary:COVID-19 vaccination recommendations prioritise healthcare workers (HCWs), considering their exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) and their key role in the functioning of healthcare systems. In the European Union/European Economic Area (EU/EEA), HCWs were considered a priority for COVID-19 revaccination during the autumn 2023 campaign [1], and the World Health Organization (WHO) recommended revaccination of HCWs 12 months after their last dose [2]. Because the Omicron sub-lineage XBB.1.5 predominated in spring 2023, the COVID-19 vaccines were adapted to target this emerging strain, and the first XBB.1.5 vaccine was authorised for use in the EU/EEA in August 2023. Omicron BA.2.86/JN.1 emerged in the EU/EEA at the end of 2023, according to data available on the European Respiratory Virus Surveillance Summary (ERVISS) [3]. Evidence for COVID-19 vaccine recommendation in the HCW population remains scarce. Within the Vaccine Effectiveness, Burden and Impact (VEBIS) project, we aimed to measure the COVID-19 vaccine effectiveness (CVE) in HCWs, in the winter season 2023/24.

Similar Items